The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
The three that you mentioned, I think, have slight advantages, the fibroblast FGF21 and TGF beta. I should mention, that is an...the other two are natural alpha-klotho and fibro FGF21. But the TGF beta receptor is normally membrane-bound. We made a soluble form of it. So all three of them tend to be soluble, and they effectively act like the young blood in rejuvenating these mice and dogs, and hopefully, soon there'll be in human clinical trials.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.